As described in a retrospective cohort of 160 advanced GC patients who underwent potentially curative surgery with or without chemotherapy, phosphorylated AKT positive patients had a good prognosis in terms of OS and relapse-free survival, suggesting that pAKT may be a biomarker for better outcomes for GC patients undergoing gastrectomy regardless of the PIK3CA mutation status [14]. The gene discussed is PIK3CA; the disease is gastric cancer.